Literature DB >> 33164940

Risk-Taking Behaviors in Huntington's Disease.

Katherine E McDonell1, Abagail E Ciriegio2, Anna C Pfalzer1, Lisa Hale1, Shuhei Shiino1, Heather Riordan3, Sarah Moroz1, R Ryan Darby1, Bruce E Compas2, Daniel O Claassen1.   

Abstract

BACKGROUND: Risky behaviors are common in Huntington's disease (HD) and can lead to significant adverse consequences. However, the prevalence and scope of these symptoms have not been studied systematically, and no empirically validated measures are available to screen for them.
OBJECTIVE: To test a novel screening tool designed to assess risk-taking behaviors in HD.
METHODS: We administered the Risk Behavior Questionnaire (RBQ-HD) to HD patients and caregivers at Vanderbilt University Medical Center between 2018-2019. Patients completed the questionnaire based on self-report; caregivers provided collateral reports. Clinical and demographic information were obtained from the electronic medical record.
RESULTS: 60 patients and 60 caregivers completed the RBQ-HD. 80% of patients (n = 48) and 91.7% of caregivers (n = 60) reported at least one risky behavior. Adverse social behaviors, impulsive/compulsive behaviors, and reckless driving were the most common behavioral domains reported. Male patients were more likely to report risky behaviors than females (92.3% vs. 70.6%, p = 0.04). The number of risky behaviors reported by patients and caregivers was negatively correlated with patient age (r = -0.32, p = 0.01; r = -0.47, p = 0.0001, respectively). Patient and caregiver reports were highly correlated in matched pairs (n = 30; r = 0.63, p = 0.0002).
CONCLUSION: These findings emphasize that risky behaviors are highly prevalent in HD and can be effectively identified through the use of a novel screening measure. We hypothesize that early pathological involvement of frontostriatal and mesolimbic networks may be important factors in the development of these behaviors.

Entities:  

Keywords:  Huntington’s disease; impulsive behavior; risk-taking; surveys and questionnaires

Year:  2020        PMID: 33164940     DOI: 10.3233/JHD-200431

Source DB:  PubMed          Journal:  J Huntingtons Dis        ISSN: 1879-6397


  3 in total

1.  Suicidality Risk Factors Across the CARE-HD, 2CARE, and CREST-E Clinical Trials in Huntington Disease.

Authors:  Andrew McGarry; Peggy Auinger; Karl D Kieburtz; Amy-Lee Bredlau; Steven M Hersch; H Diana Rosas
Journal:  Neurol Clin Pract       Date:  2022-04

2.  Manganese-induced hyperactivity and dopaminergic dysfunction depend on age, sex and YAC128 genotype.

Authors:  Jordyn M Wilcox; David C Consoli; Krista C Paffenroth; Brittany D Spitznagel; Erin S Calipari; Aaron B Bowman; Fiona E Harrison
Journal:  Pharmacol Biochem Behav       Date:  2022-01-19       Impact factor: 3.533

Review 3.  Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease.

Authors:  Lee-Anne Morris; Claire O'Callaghan; Campbell Le Heron
Journal:  Mov Disord       Date:  2022-05-02       Impact factor: 9.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.